Sharps Technology INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NASDAQ
SkyAI, Inc. announced its Board of Directors has unanimously rejected an unsolicited, non-binding proposal from Forward Industries, Inc. for a potential all-stock business combination.
NASDAQ
SkyAI, Inc. (formerly Sharps Technology, Inc.) announced a strategic business transformation to an agentic finance platform focused on emerging markets, rebranding and changing its ticker symbol.
NASDAQ
SkyAI, Inc. has formally appointed Arthur Levine as Chief Financial Officer, effective May 22, 2026.
NASDAQ
Sharps Technology, Inc. announced the appointment of Arthur Levine as interim Chief Financial Officer, effective February 17, 2026, while the company searches for a permanent replacement.
NASDAQ
Sharps Technology, Inc. announced a 90-day lock-up agreement with its Strategic Advisor, Sol Markets, signaling confidence in the company's future.
NASDAQ
Sharps Technology, Inc. has adopted updated bylaws, a revised code of ethics, and new charters for its Audit, Compensation, and Nominating & Corporate Governance Committees, effective January 15, 2026, to enhance corporate governance and compliance.
NASDAQ
Sharps Technology's independent director Annemarie Tierney resigned, citing concerns over potential conflicts of interest and related party transactions involving the company's digital asset consultants.
NASDAQ
Sharps Technology, Inc. stockholders approved the election of a director and the issuance of over 56 million common shares related to warrant exercises at a special meeting.
NASDAQ
Sharps Technology, Inc. has authorized a share repurchase program of up to $100 million for its common stock.
NASDAQ
Sharps Technology, Inc. has announced a new stock repurchase program authorizing the acquisition of up to $100 million of its common stock.
NASDAQ
Sharps Technology, Inc. has settled ongoing litigation with Barry Berler and Plasto entities, divesting its Hungarian subsidiary and certain assets, resulting in improved pro forma operating results.
NASDAQ
Sharps Technology, Inc. has secured a waiver to extend the deadline for filing its initial resale registration statement with the SEC.
NASDAQ
Sharps Technology, Inc. has entered into an At-The-Market (ATM) equity offering sales agreement to potentially raise up to $236.6 million through the sale of common stock.
NASDAQ
Sharps Technology, Inc. closed a $410.88 million private placement to fund a new digital asset treasury strategy focused on Solana (SOL).
NASDAQ
Sharps Technology announces a $400 million private placement to fund a new digital asset treasury strategy centered on Solana (SOL), alongside significant management and governance changes.
NASDAQ
8-K: Sharps Technology Issues Super-Voting Preferred Stock to Executive Chairman for Key Shareholder Vote
Sharps Technology, Inc. issued Series B Preferred Stock to its Executive Chairman, Paul K. Danner, granting significant voting power solely for a proposal to increase authorized common stock.
NASDAQ
Sharps Technology, Inc. announced the appointment of Paul Danner as Executive Chairman, replacing Soren Christiansen, and subsequent reassignments within its Audit and Compensation Committees.
NASDAQ
Sharps Technology, an innovative medical device company, announced the initiation of commercial shipments for its smart safety syringes, marking its transition to a revenue-generating stage with initial deliveries across three customer orders.
NASDAQ
Sharps Technology has received confirmation from Nasdaq that it has regained compliance with the minimum bid price and stockholders' equity requirements, allowing its common stock to continue trading on the exchange.
NASDAQ
Sharps Technology, Inc. reports having 1,019,078 shares of Common Stock outstanding as of May 7, 2025, following a recent reverse stock split.
NASDAQ
Sharps Technology announces a ~$100,000 purchase order from a Hungarian vaccine provider for SecureGard syringes, marking their transition to a revenue-producing company.
NASDAQ
Sharps Technology, Inc. has enacted a 1-for-300 reverse stock split, effective April 27, 2025.
NASDAQ
Sharps Technology has received a $400,000 purchase order from a U.S. leader in IV flushing solutions, marking the first revenue under a $50 million supply agreement.
NASDAQ
Sharps Technology, Inc. will implement a 1-for-300 reverse stock split of its common stock, effective April 27, 2025, to comply with NASDAQ's minimum bid price requirement.
NASDAQ
8-K: Sharps Technology Receives Nasdaq Letter Regarding Clawback Policy Compliance, Matter Now Closed
Sharps Technology received a letter from Nasdaq regarding a delay in adopting a Clawback Policy, but Nasdaq has since confirmed the company is now in compliance and the matter is closed.
NASDAQ
Sharps Technology, Inc. reports the exercise of 97% of its Class B cashless warrants as of April 14, 2025, following a public offering in January 2025.
NASDAQ
Sharps Technology Inc. received a delisting notification from Nasdaq due to non-compliance with the $2.5 million stockholders' equity requirement.
NASDAQ
Sharps Technology, Inc. announces the exercise of Class B Warrants following a previously reported public offering in January 2025.
NASDAQ
Sharps Technology held a special meeting where stockholders voted on a reverse stock split proposal and the authorization of warrant issuance.
NASDAQ
Sharps Technology stockholders approved the issuance of certain warrants and shares, leading to a reduced warrant exercise price of $0.292.